StockData
iBio, Inc. logo

iBio, Inc. (IBIO) stock

IBIONasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 9/30
$0.75+0.04 (+5.86%)

Close on Nov 17, 2026Market cap $48.11MP/E –Yield –

iBio cash

Cash and short-term investments held at the end of each period.

iBio's cash was $76.65M at Sep 30, 2026. For fiscal 2026 it was $88.04M, up 901.4% from the year before. Over ten years it grew 18.6% a year on average. The highest annual figure on record is $88.04M in fiscal 2026.

Annual cash

PeriodPeriod endValueChange
FY2026Jun 30, 2026$88.04M+901.4%
FY2025Jun 30, 2025$8.79M-39.1%
FY2024Jun 30, 2024$14.43M+90.3%
FY2023Jun 30, 2023$7.58M-73.6%
FY2022Jun 30, 2022$28.67M-63.0%
FY2021Jun 30, 2021$77.40M+40.4%
FY2020Jun 30, 2020$55.11M+1146.6%
FY2019Jun 30, 2019$4.42M0.0%
FY2018Jun 30, 2018$4.42M-72.3%
FY2017Jun 30, 2017$15.93M0.0%
FY2016Jun 30, 2016$15.93M+67.8%
FY2015Jun 30, 2015$9.49M+164.5%
FY2014Jun 30, 2014$3.59M-18.7%
FY2013Jun 30, 2013$4.41M-21.5%
FY2012Jun 30, 2012$5.62M+97.8%
FY2011Jun 30, 2011$2.84M+212.4%
FY2010Jun 30, 2010$909.93K–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ3 2026Sep 30, 2026$76.65M+53.9%
Q4 FY2026CQ2 2026Jun 30, 2026$88.04M+901.4%
Q3 FY2026CQ1 2026Mar 31, 2026$74.82M+1343.8%
Q2 FY2026CQ4 2025Dec 31, 2025$52.69M+627.9%
Q1 FY2026CQ3 2025Sep 30, 2025$49.81M+342.3%
Q4 FY2025CQ2 2025Jun 30, 2025$8.79M-39.1%
Q3 FY2025CQ1 2025Mar 31, 2025$5.18M-19.4%
Q2 FY2025CQ4 2024Dec 31, 2024$7.24M+78.3%
Q1 FY2025CQ3 2024Sep 30, 2024$11.26M+136.5%
Q4 FY2024CQ2 2024Jun 30, 2024$14.43M+90.3%
Q3 FY2024CQ1 2024Mar 31, 2024$6.43M-34.5%
Q2 FY2024CQ4 2023Dec 31, 2023$4.06M+2.8%
Q1 FY2024CQ3 2023Sep 30, 2023$4.76M-70.0%
Q4 FY2023CQ2 2023Jun 30, 2023$7.58M-73.6%
Q3 FY2023CQ1 2023Mar 31, 2023$9.82M-75.3%
Q2 FY2023CQ4 2022Dec 31, 2022$3.95M-91.3%
Q1 FY2023CQ3 2022Sep 30, 2022$15.88M-79.5%
Q4 FY2022CQ2 2022Jun 30, 2022$28.67M-66.1%
Q3 FY2022CQ1 2022Mar 31, 2022$39.71M-56.5%
Q2 FY2022CQ4 2021Dec 31, 2021$45.15M-41.8%
Q4 FY2021CQ2 2021Jun 30, 2021$77.40M+40.4%
Q3 FY2021CQ1 2021Mar 31, 2021$84.63M+742.9%
Q2 FY2021CQ4 2020Dec 31, 2020$91.25M+2409.0%
Q1 FY2021CQ3 2020Sep 30, 2020$77.54M+3587.3%
Q4 FY2020CQ2 2020Jun 30, 2020$55.11M+1146.6%
Q3 FY2020CQ1 2020Mar 31, 2020$10.04M+11.1%
Q2 FY2020CQ4 2019Dec 31, 2019$3.64M-72.8%
Q1 FY2020CQ3 2019Sep 30, 2019$2.10M-74.2%
Q4 FY2019CQ2 2019Jun 30, 2019$4.42M0.0%
Q3 FY2019CQ1 2019Mar 31, 2019$9.04M+166.0%
Q2 FY2019CQ4 2018Dec 31, 2018$13.36M+82.8%
Q1 FY2019CQ3 2018Sep 30, 2018$8.16M+38.0%
Q4 FY2018CQ2 2018Jun 30, 2018$4.42M-72.3%
Q3 FY2018CQ1 2018Mar 31, 2018$3.40M-72.6%
Q2 FY2018CQ4 2017Dec 31, 2017$7.31M-55.2%
Q1 FY2018CQ3 2017Sep 30, 2017$5.92M-70.6%
Q4 FY2017CQ2 2017Jun 30, 2017$15.93M–
Q3 FY2017CQ1 2017Mar 31, 2017$12.42M–
Q2 FY2017CQ4 2016Dec 31, 2016$16.33M–
Q1 FY2017CQ3 2016Sep 30, 2016$20.10M–

More iBio figures

See a number that looks wrong?